-
261
RASGRF2 as a potential pathogenic gene mediating the progression of alcoholic hepatitis to alcohol-related cirrhosis and hepatocellular carcinoma
Published 2025-01-01Subjects: Get full text
Article -
262
GGCT participates in the malignant process of hepatocellular cancer cells by regulating the PTEN/PI3K/AKT pathway through binding to EZH2
Published 2025-02-01Subjects: Get full text
Article -
263
Modelling hepatocellular carcinoma microenvironment phenotype to evaluate drug efficacy
Published 2025-01-01Subjects: Get full text
Article -
264
Metabolic reprogramming of glucose: the metabolic basis for the occurrence and development of hepatocellular carcinoma
Published 2025-02-01Subjects: “…hepatocellular carcinoma (HCC)…”
Get full text
Article -
265
Recognition of HER2 expression in hepatocellular carcinoma and its significance in postoperative tumor recurrence
Published 2019-03-01Subjects: Get full text
Article -
266
Miniaturization and characterization of patient derived hepatocellular carcinoma tumor organoid cultures for cancer drug discovery applications
Published 2025-01-01Subjects: “…Hepatocellular carcinoma organoids…”
Get full text
Article -
267
A bibliometric analysis of 30 years of research on transarterial radioembolization (TARE) for hepatocellular carcinoma
Published 2025-01-01Subjects: Get full text
Article -
268
Polyoxometalate-based injectable coacervate inhibits HCC metastasis after incomplete radiofrequency ablation via scavenging ROS
Published 2025-01-01Subjects: “…Hepatocellular carcinoma metastasis…”
Get full text
Article -
269
Donafenib combined with sintilimab for advanced hepatocellular carcinoma: a single arm phase II trial
Published 2025-02-01Subjects: “…Hepatocellular carcinoma…”
Get full text
Article -
270
-
271
A proton therapy model using discrete difference equations with an example of treating hepatocellular carcinoma
Published 2017-07-01Subjects: Get full text
Article -
272
Identification of MORF4L1 as an endogenous substrate of CRBN and its potential role as a therapeutic target in cancer
Published 2025-01-01Subjects: Get full text
Article -
273
Risk of progression and the cause of mortality at chronic viral mixed-hepatitis
Published 2013-07-01Subjects: Get full text
Article -
274
The Combination of D-TACE-HAIC, Lenvatinib, and PD-1 Inhibitors Shows Significant Clinical Efficacy in Patients with Unresectable Hepatocellular Carcinoma
Published 2025-02-01Subjects: “…unresectable hepatocellular carcinomas…”
Get full text
Article -
275
-
276
High interstitial fluid pressure enhances USP1-dependent KIF11 protein stability to promote hepatocellular carcinoma progression
Published 2025-01-01Subjects: “…Hepatocellular carcinoma…”
Get full text
Article -
277
Case report: A case of type 1 diabetes with diabetic ketoacidosis induced by envafolimab treatment in hepatocellular carcinoma
Published 2025-01-01Subjects: Get full text
Article -
278
-
279
Association of intratumoral microbiome diversity with hepatocellular carcinoma prognosis
Published 2025-01-01Subjects: Get full text
Article -
280
PPARα suppresses growth of hepatocellular carcinoma in a high-fat diet context by reducing neutrophil extracellular trap release
Published 2025-01-01Subjects: “…hepatocellular carcinoma…”
Get full text
Article